Sramana Mitra: You know, we’ve had several discussions on AI-enabled drug discovery in, towards the end of last year. We have covered AI-enabled drug discovery on our blog quite extensively. It’s an area that I think is super exciting and super promising.
Now, the conclusion that was coming out of those discussions was that drug discovery platforms that are out there, like Adam Weiss, for example, are selling only to the large pharmas. So, if you’re a researcher at a university or if you’re trying to do a startup in drug discovery, you don’t really have access to the infrastructure that you need to be able to develop your products.
>>>Sramana Mitra: Software development is getting hugely streamlined, right? The co-pilots are becoming extremely effective. So, you don’t need as many people on the software services side as well. There are a lot of co-pilot products that are getting sold into that business. So, there’s a whole market emerging out of efficiency in the software development ecosystem.
So, let’s talk a little bit about these companies that you mentioned as use cases and case studies of what you’re investing in. Cognida and Critical River are two that you just mentioned. Could you talk to us about what these companies are doing and how these models are playing into their situations?
>>>Entrepreneur, Angel Investor, and Board Member Raju Reddy discusses his AI investment thesis.
>>>Anupam Rastogi, Managing Partner at Emergent Ventures, discusses his firm’s AI investment thesis.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Android | Google Play | Stitcher | TuneIn | RSS
Entrepreneur, Angel Investor, and Board Member Raju Reddy discusses his AI investment thesis.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Android | Google Play | Stitcher | TuneIn | RSS
Will you be seeking investor introductions for your startup in 2025?
Top VC funds operate in the 98% rejection rate zone.
Let’s avoid the pitfalls of wasting time and money without achieving results.
If you are looking for investor introductions, you have to be READY.
Please post this on your wall in 2025:
“Startups: Do NOT Go to VCs as Beggars. Go as Kings.”
This is the 1Mby1M mantra and it works.
Over 99% of founders chase funding before they are fundable.
As you know, I categorically support bootstrapped entrepreneurs.
There are numerous startups now that have achieved some revenue without any external funding.
However, it has taken time. Sometimes, it has taken 5-7 years to get there.
VCs, however, are looking for velocity.
Their goal is to achieve $100M in 5-7 years.